Have You Been Screened for Kidney Disease?

March 2004
Tufts University Health & Nutrition Letter;Mar2004, Vol. 22 Issue 1, p4
Provides information on the detection and treatment of chronic kidney disease. Complications caused by kidney diseases; Percentage of people who are aware that they already have a kidney disease; Information on dialysis and kidney transplants; Description of the kidney anatomy and processes; Importance of albumin testing and blood test for creatinine in the detection of kidney disease; Treatment of disease.


Related Articles

  • OUTCOME AND ECONOMICS OF CAPD VERSUS HEMODIALYSIS AS A BRIDGE TO LIVE RELATED RENAL TRANSPLANT IN INDIA. Prasad, Narayan; Gupta, Amit; Vinod, P. B.; Sharma, R. K.; Sinha, A.; Gulati, S.; Kumar, A. // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p125 

    Aim: To analyze outcome and economics of CAPD versus hemodialysis (MHD) as a bridge to live related renal transplant. Materials and Methods: 51 patients (age 34±13 years, M:F=41:10), CAPD (n=26) and MHD (n=25) as bridge to renal transplant were included. Outcome of patients in terms of...

  • Hyperparathyroidism in chronic kidney disease: complexities within the commonplace. Cai, Michael M.; Mcmahon, Lawrence P.; Smith, Edward R.; Williams, David S.; Holt, Stephen G. // Clinical Medicine;Aug2012, Vol. 12 Issue 4, p333 

    Secondary hyperparathyroidism in patients with chronic kidney disease (CKD) is common and usually caused by associated metabolic abnormalities, in particular, hypocalcaemia and hyperphosphataemia. Nevertheless, other causes of hyperparathyroidism can exist concurrently with CKD, challenging...

  • Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Specter, Richard; Sanchorawala, Vaishali; Seldin, David C.; Shelton, Anthony; Fennessey, Salli; Finn, Kathleen T.; Zeldis, Jerome B.; Dember, Laura M. // Nephrology Dialysis Transplantation;Mar2011, Vol. 26 Issue 3, p881 

    Background. Lenalidomide is an immunomodulatory agent used to treat plasma cell dyscrasias. We previously observed worsening of kidney function in a high proportion of patients with AL amyloidosis during lenalidomide treatment. The objective of this study is to characterize alterations in kidney...

  • The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Gill, J. S.; Rose, C.; Pereira, B. J. G.; Tonelli, M. // Kidney International;Mar2007, Vol. 71 Issue 5, p442 

    Analyses describing outcomes of kidney transplantation usually exclude the survival of wait-listed patients and dialysis patients with failed kidney transplants, and thus reflect only a portion of the typical transplant process. We determined death rates during the continuum of wait-listing,...

  • Renal replacement therapy in Ukraine: epidemiology and international comparisons. Kolesnyk, Inna; Noordzij, Marlies; Kolesnyk, Mykola; Kulyzky, Mykola; Jager, Kitty J. // Clinical Kidney Journal;Jun2014, Vol. 7 Issue 3, p330 

    Background Little is known about the status of renal replacement therapy (RRT) in the post-Soviet countries. We therefore investigated the epidemiology and treatment outcomes of RRT in Ukrainian patients and put the results into an international perspective. Methods Data from the Ukrainian...

  • Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease. Pastores, Gregory M.; Boyd, Ellen; Crandall, Kerry; Whelan, Alison; Piersall, Linda; Barnett, Natalie // Nephrology Dialysis Transplantation;Jul2007, Vol. 22 Issue 7, p1920 

    Background. Fabry disease (FD) is caused by an X-linked deficiency in the activity of α-galactosidase A and the resultant accumulation of globotriaosylceramide (Gb3) in multiple tissues. Nearly all classically affected males with FD experience kidney dysfunction, with progression to end-stage...

  • The pattern of excess cancer in dialysis and transplantation. Stewart, John H.; Vajdic, Claire M.; Van Leeuwen, Marina T.; Amin, Janaki; Webster, Angela C.; Chapman, Jeremy R.; McDonald, Stephen P.; Grulich, Andrew E.; McCredie, Margaret R. E. // Nephrology Dialysis Transplantation;Oct2009, Vol. 24 Issue 10, p3225 

    Background. After transplantation, cancer risk varies from no increase for several common cancers to a many-fold increase for a number of, chiefly virus-associated, cancers. The smaller excess of cancer in dialysis has been less well described, but two studies suggested that impaired immunity...

  • VOCATIONAL REHABILITATION FOR DIALYSIS AND TRANSPLANT PATIENTS. Brown, Cathy J.; Ryersbach, Vera // Health & Social Work;May1980, Vol. 5 Issue 2, p22 

    Although many patients with end-stage renal disease identify work as a major factor in determining the quality of their lives, vocational rehabilitation counselors often have little success with these clients. In Vermont, a statewide project pinpointed the difficulties in counseling renal...

  • Metabolic problems in diabetic patients undergoing renal transplantation. Palumbo, Pasquale J.; Woods, John E.; Jonson, William J.; Service, F. John // Kidney International Supplement;Oct1974, Issue 1, pS-58 

    This article informs that the patient with diabetes mellitus is at high risk because of the widespread complications of the disease, microangiopathy, macroangiopathy and neuropathy. This paper evaluates the effect of intermittent hemodialysis and renal transplantation on weight change during...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics